Medicare shock sends health insurance companies reeling

Insurers took a sharp hit this week after the White House delivered an unwelcome policy surprise.

President Trump is proposing a far smaller than expected payment increase for Medicare Advantage plans, catching both the healthcare sector and the broader market flat-footed.

The result was a swift selloff that exposes just how open some sectors remain to policy risk.

Getting into the details

The Centers for Medicare and Medicaid Services proposed an average 0.09% payment increase for plans in 2027, far below the 4% to 5% investors had expected. That’s important because more than half of all Medicare beneficiaries rely on such private plans.

Here’s why the market reacted so strongly:

• Margins are already under pressure from higher medical usage, rising drug costs, and home-health spending.
• CMS also proposed changes to risk adjustment, a key system that determines how much insurers are paid for sicker patients.
• CFRA warns that even if final rates improve, they are unlikely to match the more than 5% increase insurers most recently received.

For its part, CMS says the proposal reflects cost trends and aims to protect taxpayers. But insurers and analysts argue it risks benefit cuts or higher out-of-pocket expenses for seniors.

The final rates won’t be set for more than two months, but institutional research suggests policy headwinds will stick around for a while.

UNH leads the plummet

UnitedHealth Group, the industry bellwether, took an outside hit. Shares dropped nearly 20% after earnings that barely met expectations collided with the CMS announcements.

Digging into the report shows that EPS came in as expected, but revenue missed slightly.

The company's medical care ratio remains elevated, signaling ongoing cost pressures. And even though management's 2026 profits forecast is slightly above estimates, policy concerns overshadowed the optimistic outlook.

Peers like Humana, CVS Health, and Elevance also fell, underscoring that this wasn’t a company-specific issue but rather a sector-wide recalibration.

Healthcare insurers might look defensive, but Medicare-heavy business models are inexorably linked to DC politics.

For retail investors, it’s a reminder that even “safe” sectors aren’t policy-proof, so it’s always important to know where a company’s revenue really comes from.